- Home
- CRVO vs FBLG Comparison
CRVO vs FBLG Comparison
Compare CRVO & FBLG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRVO
- FBLG
- Stock Information
- Founded
- CRVO 2001
- FBLG 2021
- Country
- CRVO United States
- FBLG United States
- Employees
- CRVO N/A
- FBLG N/A
- Industry
- CRVO Biotechnology: Pharmaceutical Preparations
- FBLG
- Sector
- CRVO Health Care
- FBLG
- Exchange
- CRVO Nasdaq
- FBLG NYSE
- Market Cap
- CRVO 98.3M
- FBLG 91.0M
- IPO Year
- CRVO N/A
- FBLG 2024
- Fundamental
- Price
- CRVO $2.11
- FBLG $1.75
- Analyst Decision
- CRVO Buy
- FBLG Strong Buy
- Analyst Count
- CRVO 8
- FBLG 4
- Target Price
- CRVO $38.75
- FBLG $13.00
- AVG Volume (30 Days)
- CRVO 303.4K
- FBLG 143.9K
- Earning Date
- CRVO 11-12-2024
- FBLG 02-02-2025
- Dividend Yield
- CRVO N/A
- FBLG N/A
- EPS Growth
- CRVO N/A
- FBLG N/A
- EPS
- CRVO N/A
- FBLG N/A
- Revenue
- CRVO $10,066,550.00
- FBLG N/A
- Revenue This Year
- CRVO $34.17
- FBLG N/A
- Revenue Next Year
- CRVO N/A
- FBLG N/A
- P/E Ratio
- CRVO N/A
- FBLG N/A
- Revenue Growth
- CRVO 116.29
- FBLG N/A
- 52 Week Low
- CRVO $1.80
- FBLG $1.08
- 52 Week High
- CRVO $26.38
- FBLG $46.00
- Technical
- Relative Strength Index (RSI)
- CRVO 28.68
- FBLG 37.40
- Support Level
- CRVO $2.03
- FBLG $1.86
- Resistance Level
- CRVO $2.17
- FBLG $2.12
- Average True Range (ATR)
- CRVO 0.16
- FBLG 0.22
- MACD
- CRVO 0.30
- FBLG -0.01
- Stochastic Oscillator
- CRVO 23.08
- FBLG 4.29
About CRVO CervoMed Inc.
CervoMed Inc is a clinical-stage biotechnology company. It is focused on developing treatments for age-related neurologic disorders. The company's product candidate, Neflamapimod has the potential to treat and improve synaptic dysfunction, the reversible aspect of the underlying disease processes in DLB and certain other neurological disorders.
About FBLG FIBROBIOLOGICS INC
FibroBiologics Inc is a clinical-stage cell therapy company focused on developing and commercializing fibroblast-based therapies for patients suffering from chronic diseases with significant unmet medical needs, including degenerative disc disease, multiple sclerosis, wound healing, and certain cancers, and potential extension of life applications including thymic and splenic involution reversal.